PEAK6 Investments »

Immunovant shares owned by PEAK6 Investments

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by PEAK6 Investments from 13F filings

Historical chart of PEAK6 Investments investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by PEAK6 Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by PEAK6 Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $951k 29k 32.31
2023-09-30 $579k 15k 38.39
2023-06-30 $247k 13k 18.97
2022-06-30 $247k 13k 18.97

More positions owned by PEAK6 Investments

NVIDIA Corporation Call Option (NVDA)
SPDR S&P 500 ETF TR Tr Unit Call Option (SPY)
Tesla Motors Call Option (TSLA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Meta Platforms Cl A Call Option (META)
Broadcom Call Option (AVGO)
Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Microstrategy Cl A New Call Option (MSTR)
Super Micro Computer Call Option (SMCI)
Microsoft Corporation Call Option (MSFT)
Apple Call Option (AAPL)
Spdr Gold Tr Gold Shs Call Option (GLD)
Advanced Micro Devices Call Option (AMD)
Qualcomm Call Option (QCOM)
Alphabet Cap Stk Cl A Call Option (GOOGL)

View all positions for PEAK6 Investments

Top funds holding Immunovant

FMR
Vanguard Group
BlackRock
Armistice Capital
Deep Track Capital
State Street Corporation
Viking Global Investors
Perceptive Advisors
Alpine Partners VI
Woodline Partners
T. Rowe Price Investment Management
Geode Capital Management
Paradigm Biocapital Advisors
T. Rowe Price Associates
Pictet Asset Management Holding SA

View all funds holding Immunovant